胺碘酮联合美托洛尔治疗冠心病心律不齐的疗效分析  

Effect of Amiodarone Combined With Metoprolol in the Treatment of Coronary Heart Disease Arrhythmia

作　　者：王彬[1] 王增琛[1] 高金波[1] 

机构地区：[1]黑龙江省鸡西市人民医院,158100

出　　处：《中国卫生标准管理》2015年第32期113-114,共2页China Health Standard Management

摘　　要：目的探究胺碘酮联合美托洛尔治疗冠心病心律不齐的临床疗效。方法对照分析我院102例冠心病心律不齐患者在不同用药下的治疗效果。结果本次治疗中,观察组有效率为92.15%,对照组有效率为70.58%。在心律转复和见效时间方面,观察组数据优于对照组;在不良反应方面,两组患者差异无统计学意义(P>0.05)。结论胺碘酮联合美托洛尔治疗冠心病心律不齐具有好的临床效果且用药安全。Objective To explore clinical efficacy of amiodarone combined with metoprolol in the treatment of coronary heart disease arrhythmia. Methods Comparative analysis of our hospital 102 cases of coronary heart disease arrhythmia in patients with different medication treatment. Results The effective rate of the observation group was 92.15% in the treatment. Efficiency was 70.58% in the control group. In rhythm conversion complex and effective time,observation data group was significantly better than the control group. In adverse reactions, patients in the two groups in adverse reactions without significant difference（P〉0.05）,the difference had not statistical value. Conclusion Amiodarone combined with metoprolol in the treatment of coronary heart disease arrhythmia has good clinical effect and safety.

关 键 词：胺碘酮 美托洛尔 冠心病心律不齐 临床疗效 

分 类 号：R541.4[医药卫生—心血管疾病]